Navigation Links
sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
Date:4/28/2011

rong allergy season. Despite major disasters occurred at the beginning of March, our Kawagoe factory and our distribution centers were unaffected.

First-quarter net sales in the U.S. reached euro 2,165 million, down 3.3%. This decrease reflected the impact of generics of Lovenox®, Ambien®CR, and Taxotere® which was partially offset by the successful launch of Allegra® OTC (euro 80 million) and strong growth of Lantus®, Multaq®, Jevtana® and Merial.

Western Europe recorded net sales in the first quarter of euro 2,251 million, a decrease of 13.5% and were impacted by generic competition to Plavix® (-46.6%) and Taxotere® (-61.3%) and austerity measures.

R&D update Since the last R&D update on February 9, several compounds/Vaccines entered Phase I, Phase II or Phase III and additional partnerships with companies and academia were signed. At the end of April, sanofi-aventis portfolio comprised 64 new molecular entities and vaccines in clinical development of which 17 are in Phase III or have been submitted to the health authorities for approval.

With the completion of the acquisition of Genzyme in April, sanofi-aventis' R&D significantly expanded its presence in biotechnology and in the Boston area, a region recognized worldwide for excellence in the sciences. Genzyme has enriched the Group's pipeline with 10 new molecular entities currently in clinical development. Genzyme R&D has three near term opportunities: alemtuzumab for multiple sclerosis, mipomersen for patients with homozygous familial hypercholesterolemia (hoFH) or severe heterozygous familial hypercholesterolemia (heFH) and eliglustat an oral therapy for type 1 Gaucher Disease.

The entire Genzyme pipeline will be subject to a thorough portfolio analysis in the coming months to identify portfolio priorities.

Throughout 2011, fu
'/>"/>

SOURCE sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
2. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
3. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
8. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
9. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
11. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... EDGE, N.J. , May 23, 2013 ... a commercial stage medical device company that develops and ... successful completion of its rights offering.  In addition, the ... March 2011 warrants expired on May 17, 2013. ... of $3.0 million from the rights offering.   A portion ...
(Date:5/23/2013)... HOUSTON , May 23, 2013  A recently ... in Houston, Texas , demonstrates that ... simultaneously increasing cancer detection. The study, ... An Observational Study," was led by Stephen ... June issue of the American Journal of Roentgenology ...
(Date:5/23/2013)... , May 23, 2013 More than ... may not benefit from chemotherapy and still have excellent ... launch of one of the largest sources of online ... website and interactive Facebook page provide recently diagnosed women ... can safely avoid chemotherapy. "We anticipate these ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
... (Nasdaq: REGN ) will webcast its presentation ... September 13, 2010.  The presentation is scheduled for 1:00 ... the Company,s web site, www.regeneron.com , on the ... will be available after the live webcast through October ...
... SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification -- SHANGHAI, Sept. 3 /PRNewswire-Asia/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
Cached Medicine Technology:Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification 2Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification 3Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification 4Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification 5Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification 6Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification 7
(Date:5/25/2013)... May 25, 2013 Radius Engineering ... shelter company in the US and has been ... for over 35 years. M.E. and President, Walton ... of NBC Weapon Fundamentals and Shelter Engineering Standards, ... bible on shelter engineering. McCarthy is considered the ...
(Date:5/25/2013)... NY (PRWEB) May 25, 2013 On May ... many people do not wish to discuss or plan for ... life. FuneralFinancials.com released a Must-Do List to ... 1. Funeral Financials recommends, “Creating a personal fact sheet.” , ... to organize financial information and personal data. It may ...
(Date:5/25/2013)... On May 25, Voices Against Brain Cancer, ... comments on a new study by the Max Planck ... plasma into brain cancer treatment may help when dealing ... Science Daily article, physicists from the Max Planck ... the “synergistic effect of cold atmospheric plasma -- a ...
(Date:5/25/2013)... According to world-renowned scholars, Queen Cleopatra ... women that ever lived. Cleopatra’s legendary beauty moved nations ... most powerful men in her time. Cleopatra was also ... her skin glowing and fresh, from her legendary milk ... oil and cyprus grass. , Cleopatra was said to ...
(Date:5/25/2013)... Bradley, Illinois (PRWEB) May 25, 2013 ... assisted living community, is hosting an American Red Cross ... May 30. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... give the Gift of Life," says Andrea Arview Frey, ...
Breaking Medicine News(10 mins):Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2
... ... online nursing uniform store. , ... (PRWEB) February 17, 2010 -- MyNursingUniforms (MNU), a leader in online retail for nursing uniforms ... offerings., , ,MNU made the expansion to their online store in both the shoe and ...
... ... ... the first consumer reference guide for medical tourism, is pleased to announce the release ... healthcare facilities. FOCUS ON: PCMC addresses Prince Court’s myriad signature and concierge services, including ...
... ... Physician Portal™ solution to the US marketplace. , ... (PRWEB) February 17, 2010 -- ... is delivering its Integrated Clinical Environment (Sunquest ICE™) Physician Portal™ solution to the ...
... conducted by the Battelle Memorial Institute shows Mayo Clinic ... including $9.6 billion in Minnesota. The $9.6 billion impact ... and lodging industry ($1.8 billion), motor vehicle manufacturing ($3.9 ... of job creation, Mayo Clinic employs more than 57,000 ...
... , ... Marco Island, Florida, participants at "Seduction of Spirit" have a rare opportunity to spend a ... Chopra, David Simon, and the Chopra Center for Wellbeing. , ... Marco Island, Fla. (PRWEB) February 16, 2010 -- This March ...
... Feb. 16 Patients enrolled in Anthem Blue Cross ... and costly awakening the next time they visit a physical ... company is slashing payment for physical therapy services to a ... therapists to continue providing care to enrollees of Anthem Blue ...
Cached Medicine News:Health News:MyNursingUniforms Adds Skechers Brand Name Shoes and Scrubs to Store 2Health News:Prince Court Medical Center in Malaysia to Release First Patients Beyond Borders FOCUS ON:™ 2Health News:Prince Court Medical Center in Malaysia to Release First Patients Beyond Borders FOCUS ON:™ 3Health News:Sunquest Introduces Integrated Clinical Environment Physician Portal Solution in US 2Health News:Mayo Clinic responsible for $22 billion in economic impact, including $9.6 billion in Minnesota 2Health News:Mayo Clinic responsible for $22 billion in economic impact, including $9.6 billion in Minnesota 3Health News:Tired of Snow, Sleet, and Stress? Join Deepak Chopra for a Week-Long Meditation Retreat this March in Florida's Warm Sunshine 2Health News:Tired of Snow, Sleet, and Stress? Join Deepak Chopra for a Week-Long Meditation Retreat this March in Florida's Warm Sunshine 3Health News:Payments for Physical Therapy Services to be Drastically Cut by Anthem Blue Cross of California 2
... The CARDIA PDA Closure Device has been ... Patent Ductus Arteriosus. Introduced through standard venous ... and reliable method for the percutaneous closure ... from 2mm-10mm within the ductus.,An integral locking ...
Stainless steel plain Steinman Pins available in point types A through F....
Full pin skeletal traction pins with cove point....
Calibrated Guide Pins have a 12.7 mm calibration and are available in plain, with a threaded tip, or with a trocar point....
Medicine Products: